The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan

OBJECTIVE: Hyponatremia is frequently observed in patients with decompensated liver cirrhosis and it is also related to a poor prognosis. The vasopressin V2-receptor antagonist tolvaptan is used to treat cirrhotic patients with ascites and increases the serum sodium (Na) level. In this study, we inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogiso, Tomomi, Kobayashi, Mutsuki, Yamamoto, Kuniko, Ikarashi, Yuichi, Kodama, Kazuhisa, Taniai, Makiko, Torii, Nobuyuki, Hashimoto, Etsuko, Tokushige, Katsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725852/
https://www.ncbi.nlm.nih.gov/pubmed/28943585
http://dx.doi.org/10.2169/internalmedicine.9033-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725852/
https://www.ncbi.nlm.nih.gov/pubmed/28943585
http://dx.doi.org/10.2169/internalmedicine.9033-17

Ejemplares similares